Law360, New York (October 18, 2006, 12:00 AM EDT) -- Two weeks after being slapped with a patent infringement suit involving anti-congestion drug Mucinex, Mutual Pharmaceutical Company Inc. has lashed back in a countersuit against Adams Respiratory Therapeutics Inc. alleging violations of antitrust laws.
The lawsuit, filed by Mutual and United Research Laboratories Inc., charges Adams with multiple antitrust counterclaims, tortious interference, and unfair competition, according to a company statement. The complaint was not immediately available in court dockets, and the company did not return phone calls.
The move comes on the heels of Adams’ patent...
Mucinex War Heats Up With Antitrust Countersuit
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
